Form 4: Mirum Pharmaceuticals SVP, Global Controller, Jolanda Howe, Reports Stock Transactions
SEC Form 4 Filing
Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On January 6, 2025, Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, had 1,250 restricted stock units vest.
- These units convert to common stock.
- Following the vesting, Howe sold 750 shares of common stock on January 7, 2025, at a price of $42.8153 per share to cover tax withholding obligations.
- After these transactions, Howe directly owns 2,926 shares of Mirum Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company insider, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their trading activities and ownership positions.
Key Dates
| Date | Description |
|---|---|
| January 6, 2023 | First vesting date of restricted stock units (1,250 shares) |
| January 6, 2024 | Second vesting date of restricted stock units (1,250 shares) |
| January 6, 2025 | Restricted stock units vest (1,250 shares) |
| January 7, 2025 | Shares sold to cover tax withholding obligations |
| January 8, 2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.